Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 10/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.73 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.41 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.40 |
| ▸ | TUBB | P07437 | 1/20 | 0.40 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.40 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.40 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.40 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.40 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.40 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.40 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.40 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.40 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.40 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.40 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10323009 | 0.92 | SLC22A12 (0.69) | SLC22A12CYP2C9ABCG2LMNATAS1R3 | |
| SCHEMBL10323032 | 0.92 | SLC22A12 (0.72) | SLC22A12CYP2C9ABCG2LMNATUBB4A | |
| SCHEMBL10322430 | 0.90 | SLC22A12 (0.76) | SLC22A12CYP2C9ABCG2LMNATAS1R3 | |
| SCHEMBL10323647 | 0.89 | SLC22A12 (0.74) | SLC22A12CYP2C9ABCG2LMNATUBB4A | |
| SCHEMBL10323650 | 0.89 | SLC22A12 (0.65) | SLC22A12CYP2C9ABCG2LMNA | |
| SCHEMBL10323573 | 0.89 | SLC22A12 (0.65) | SLC22A12CYP2C9ABCG2LMNA | |
| SCHEMBL31582634 | 0.88 | SLC22A12 (0.70) | SLC22A12CYP2C9ABCG2LMNAHTT | |
| SCHEMBL28004025 | 0.88 | SLC22A12 (0.63) | SLC22A12CYP2C9ABCG2LMNATUBB4A | |
| SCHEMBL10321747 | 0.88 | SLC22A12 (0.68) | SLC22A12CYP2C9ABCG2LMNATUBB4A | |
| SCHEMBL10322041 | 0.86 | SLC22A12 (1.00) | SLC22A12CYP2C9ABCG2LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431270-A | Multi-tenor preparation method of German | 南京联智医药科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-121085867-A | Purification method of key intermediate of dorranolazine | 山东科新药业有限公司 | 2025-12-09 | — | — | CN | disclosed |
| WO-2025103334-A1 | PREPARATION METHOD AND USE OF DOTINURAD | 广东东阳光药业股份有限公司 | 2025-05-22 | — | — | WO | disclosed |
| CN-118271256-A | Synthesis method of donede | 杭州中美华东制药有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118271255-A | Preparation method of donod | 杭州中美华东制药有限公司 | 2024-07-02 | — | — | CN | disclosed |
| EP-2484669-B1 | PHENOL DERIVATIVES | FUJI YAKUHIN CO LTD (JP) | 2015-07-29 | — | — | EP | disclosed |
| US-8367843-B2 | Phenol derivative | FUJI YAKUHIN CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| EP-2484669-A1 | NOVEL PHENOL DERIVATIVE | Fuji Yakuhin Co., Ltd. (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-20120184587-A1 | NOVEL PHENOL DERIVATIVE | FUJI YAKUHIN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120184587-A1 | NOVEL PHENOL DERIVATIVE | XDH, REN, UTS2R | SLC22A12 379/4885CYP2C9 184/4885ABCG2 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.